Login / Signup
Qingyu Xu
ORCID
Publication Activity (10 Years)
Years Active: 2019-2019
Publications (10 Years): 1
Top Topics
Ejection Fraction
Disease Activity
Peritoneal Dialysis
Acute Lymphoblastic Leukemia
Top Venues
International journal of cancer
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Qingyu Xu
,
Yan Li
,
Yu Jing
,
Na Lv
,
Lili Wang
,
Yonghui Li
,
Li Yu
Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen.
International journal of cancer
146 (5) (2019)